Open for inclusion

Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma (B-CAP)

Cancer type: Lymphoma

Phase: II

Principal Investigator: Joergensen Judit

Country: DK

Keywords: Denmark, Aarhus, Århus, Hodgkin lymphoma

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02191930